Signature of Circulating microRNAs in Patients with Acute Heart Failure
Ekaterina S. Ovchinnikova(University Medical Center Groningen), Eugène Berezikov(Royal Netherlands Academy of Arts and Sciences), John G.F. Cleland(University of Glasgow), Piotr Ponikowski(Wroclaw Medical University), Pim van der Harst(University Medical Center Utrecht), Beth A. Davison(Inserm), Rudolf A. de Boer(Uppsala University), Licette C.Y. Liu(University Medical Center Groningen), Marco Metra(Vita-Salute San Raffaele University), Daniel M. Bloomfield(Columbia University), Yigal M. Pinto(Amsterdam Neuroscience), Gad Cotter(Assaf Harofeh Medical Center), Daniela Schmitter(Momentum Research), Dirk J. van Veldhuisen(University Medical Center Groningen), Adriaan A. Voors(University Medical Center Groningen), Sai͏̈d Laribi(Université de Tours), Alexandre Mebazaa(Délégation Paris 5), Sven Meyer(Universität Hamburg), Jozine M. ter Maaten(University Medical Center Groningen), Mattia A. E. Valente(University Medical Center Groningen), Peter van der Meer(University Medical Center Groningen), Michael M. Givertz(Brigham and Women's Hospital), Eline L. Vegter(University Medical Center Groningen), Christopher M. O’Connor(Inova Health System), John R. Teerlink(San Francisco VA Medical Center)
Cited by 203
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k